AML cell-derived extracellular vesicles (EVs) inhibit the activity of CD4+ T cells by carrying immune suppressive factors, such as PD-L1, TGF-β1 or miRNA, thereby promoting immune evasion in leukemia [77]. This evidence concerns the gene CD4 and leukemia.